|
- Small Cell Lung Cancer in 2024: Treatment Advances - Medscape
Dr Kris reviews the latest treatment advances in small cell lung cancer, including new standards of care and emerging therapies in 2024
- Zenocutuzumab Effective Against NRG1 Fusion Cancers - Medscape
The bispecific antibody shows particularly promising results in non–small cell lung cancer (NSCLC) and pancreatic cancer patients, with responses lasting a median of 11 1 months
- Changes in the Treatment Landscape of Early-Stage Non–Small Cell Lung . . .
Narjust Florez, MD, reflects on the significant changes in the treatment landscape of early-stage non-small cell lung cancer in recent years
- Evaluation and Management of Small Pulmonary Nodules - Page 3 - Medscape
Common benign etiologies of lung nodules with an air bronchogram include pulmonary lymphoma, sarcoidosis and round pneumonia [35, 55, 56] Cavitation can be present in both benign and malignant
- ASCO Details How to Manage Ongoing Cancer Drug Shortage
The group noted this strategy specifically for patients with non-small cell lung cancer or testicular germ cell cancers, but also acknowledged that this option "may cause additional financial
- EU Panel Likes 4 New Cancer Products - Medscape
The EMA's CHMP has recommended a new drug for non-small cell lung cancer and one for gastric cancer, a new drug for chemotherapy-induced neutropenia, and a new imaging product
- Potential Drivers of LCINS - Medscape
An American Cancer Society expert urges clinicians to advocate for action in the healthcare industry to help combat climate change and its effects on lung cancer incidence
- Early Detection and Screening of Lung Cancer - Page 2 - Medscape
The rationale for developing effective lung cancer screening stems from the fact that lung cancer causes 1 3 million deaths worldwide each year and accounts for more cancer deaths than breast
|
|
|